Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW406381 in Adults With Rheumatoid Arthritis
NCT00113308Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2005
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 33
01
Overview
A Phase 3 trial of GW406381 in rheumatoid arthritis (RA), sponsored by GSK. Started Jun 2005; status: completed.
02
Drugs
GW406381
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00113308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00113308.